--- title: "Why Annex 1 Implementation Doesn't End at the First CCS Draft" description: "Annex 1 implementation does not end with your first CCS. Learn how to keep contamination control risk-based, current and inspection-ready." url: https://qbdgroup.com/en/blog/annex-1-implementation-contamination-control-strategy type: "Blog post" language: en published: 2026-10-07 author: "Jo Doucet & Stan Van Kerkhoven" category: "Qualification & Validation" publisher: "QbD Group" citation: "QbD Group, \"Why Annex 1 Implementation Doesn't End at the First CCS Draft\", https://qbdgroup.com/en/blog/annex-1-implementation-contamination-control-strategy" --- # Why Annex 1 Implementation Doesn't End at the First CCS Draft > Annex 1 implementation does not end with your first CCS. Learn how to keep contamination control risk-based, current and inspection-ready. Since the revised Annex 1 entered into application in August 2023, sterile manufacturers have been working under its updated requirements. The focus has gradually shifted from **preparing for Annex 1 to applying it in daily operations**. And the challenges teams face today look very different from those of the early implementation phase. That is because Annex 1 is not a document you finish. **It is a framework you keep operating, and some of the hardest decisions appear after the first implementation wave.** This focus on ongoing application is consistent with the way the revised Annex 1 was designed. It is built on quality risk management principles, in line with ICH Q9(R1) and ICH Q10, which means decisions need to be justified, documented and revisited as conditions change. A site can have a polished Contamination Control Strategy (CCS) and still struggle to explain **how it stays current**. And that is where implementation becomes an ongoing governance challenge. ## In This Blog Post - Why Annex 1 implementation continues beyond the first CCS - How to keep your Contamination Control Strategy current over time - What single-use systems mean for contamination control - Why filter strategy and zone monitoring should form a coherent control logic - How cross-functional governance helps turn Annex 1 requirements into sustainable routine practice ## Annex 1 Implementation Is a Cross-Functional Responsibility As Annex 1 moves from initial implementation into routine operation, the questions it creates no longer sit neatly within a single function. Quality Assurance, Engineering, Manufacturing and Microbiology each hold part of the answer. And some of the most important decisions cut directly across those boundaries. For example: - How should a change be assessed against the CCS? - When should that change trigger a CCS update? - How should a monitoring programme evolve when conditions change? - Who owns the resulting actions and documentation? The challenge is therefore no longer simply demonstrating that Annex 1 requirements were implemented. **It is demonstrating that the system continues to work as products, processes, equipment and risks evolve.** ## Keeping Your Contamination Control Strategy Current Annex 1 expects the CCS to be reviewed regularly and updated where appropriate. What it does not prescribe is exactly: - how often that review should happen - who owns each element - which events should trigger a revision As a result, sites have adopted different approaches. Some perform an **annual review**, potentially linked to the pharmaceutical quality system's management review. Others use an **event-driven approach**, updating the CCS following relevant deviations or changes. A third option combines both in a **hybrid model**. Each approach can work. The more important question is whether the chosen approach is **documented, risk-based and consistent with the pharmaceutical quality system described in EU GMP Chapter 1**. If an inspector asks how a recent change made its way into the CCS, the answer needs to be traceable. A general statement that the CCS is "periodically reviewed" is not enough. ## Single-Use Systems Shift the Contamination Control Question Single-use technology introduces another area that requires careful attention. It can reduce cleaning burdens and cross-contamination risk. At the same time, it shifts part of the contamination control responsibility towards: - suppliers - assembly practices - connection controls - integrity controls Annex 1 expects manufacturers to assess single-use systems with the same rigour applied to other critical components. That includes considering: - supplier controls - sterilisation - system integrity - interactions between the product and materials in contact with it The difficult question is often not **whether** these factors need to be assessed, but **how far that assessment needs to go for a particular application and how much supplier information is sufficient**. Those decisions can influence qualification, validation and routine monitoring simultaneously. Which is precisely why they rarely belong to one department alone. ## Filter Strategy and Zone Monitoring Should Tell the Same Story Filter strategy and zone monitoring are often approached as separate technical questions. In practice, they form part of the same contamination control logic. On one side is **filter strategy**. Annex 1 expects the integrity of the sterilised filter assembly to be verified before use through Pre-Use Post-Sterilisation Integrity Testing (PUPSIT). Where a site considers alternative approaches, including configurations involving multiple filters, the justification needs to rest on a thorough, documented risk assessment. On the other side is **zone monitoring**. How closely Grade A and surrounding areas should be monitored, which methods should be used and at what frequency are questions framed by risk rather than by a single fixed recipe. Treating these as isolated decisions can make the overall control strategy harder to defend. Sites that approach them as parts of one coherent control logic are better positioned to explain how those decisions collectively support: - qualification - monitoring - batch release confidence - the evidence available to justify the chosen approach Ultimately, an inspector is unlikely to be interested only in *what* choice was made. The more important question is: **Why was this approach appropriate for this process, at this site, based on this risk?** That answer needs to be supported by evidence. ## From Annex 1 Requirement to Routine Practice CCS governance, single-use systems, filter strategy and zone monitoring are only a few of the topics Annex 1 puts on the table. But they illustrate the wider implementation challenge particularly well. Each sits at the point where a principle written in Annex 1 needs to become a practical decision on the shop floor, with consequences for: - validation - monitoring - supplier relationships - day-to-day operations That transition from requirement to routine is where Annex 1 implementation ultimately succeeds or fails. The most useful question is therefore no longer simply: **What does Annex 1 require?** It is: **How do we apply, document and sustain that requirement at our specific site, with our products, equipment, processes and resources?** Sites that can answer that question with evidence rather than general statements are better positioned when an inspection arrives or when conditions change. Because ultimately, Annex 1 implementation is about **turning regulatory text into practice that holds up over time**. Annex 1 compliance does not end once the first CCS has been written or the initial implementation programme has closed. Maintaining an effective contamination control strategy requires ongoing risk assessment, cross-functional governance and the ability to demonstrate why controls remain appropriate as processes and conditions evolve. QbD Group supports sterile manufacturers across Annex 1 implementation, contamination control strategy, quality risk management, qualification, validation and ongoing GMP compliance. **Is your CCS still reflecting how your site operates today? [Get in touch with our experts](/en/contact) to turn Annex 1 requirements into a contamination control strategy that remains practical, traceable and inspection-ready.** --- Source: https://qbdgroup.com/en/blog/annex-1-implementation-contamination-control-strategy — © QbD Group. Quote freely with attribution and a link back.